𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Genome-wide expression and copy number analysis identifies driver genes in gingivobuccal cancers

✍ Scribed by Srikant Ambatipudi; Moritz Gerstung; Manishkumar Pandey; Tanuja Samant; Asawari Patil; Shubhada Kane; Rajiv S. Desai; Alejandro A. Schäffer; Niko Beerenwinkel; Manoj B. Mahimkar

Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
708 KB
Volume
51
Category
Article
ISSN
1045-2257

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

The molecular mechanisms contributing to the development and progression of gingivobuccal complex (GBC) cancers—a sub‐site of oral cancer, comprising the buccal mucosa, the gingivobuccal sulcus, the lower gingival region, and the retromolar trigone–remain poorly understood. Identifying the GBC cancer‐related gene expression signature and the driver genes residing on the altered chromosomal regions is critical for understanding the molecular basis of its pathogenesis. Genome‐wide expression profiling of 27 GBC cancers with known chromosomal alterations was performed to reveal differentially expressed genes. Putative driver genes were identified by integrating copy number and gene expression data. A total of 315 genes were found differentially expressed (P ≤ 0.05, logFC > 2.0) of which 11 genes were validated by real‐time quantitative reverse transcriptase‐PCR (qRT‐PCR) in tumors (n = 57) and normal GBC tissues (n = 18). Overexpression of LY6K, in chromosome band 8q24.3, was validated by immunohistochemical (IHC) analysis. We found that 78.5% (2,417/3,079) of the genes located in regions of recurrent chromosomal alterations show copy number dependent expression indicating that copy number alteration has a direct effect on global gene expression. The integrative analysis revealed BIRC3 in 11q22.2 as a candidate driver gene associated with poor clinical outcome. Our study identified previously unreported differentially expressed genes in a homogeneous subtype of oral cancer and the candidate driver genes that may contribute to the development and progression of the disease. © 2011 Wiley Periodicals, Inc.

📜 SIMILAR VOLUMES

Genome-wide copy number analyses identif
Genome-wide copy number analyses identified novel cancer genes in hepatocellular carcinoma
✍ Deshui Jia; Lin Wei; Weijie Guo; Ruopeng Zha; Meiyan Bao; Zhiao Chen; Yingjun Zh 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 874 KB

A powerful way to identify driver genes with causal roles in carcinogenesis is to detect genomic regions that undergo frequent alterations in cancers. Here we identified 1,241 regions of somatic copy number alterations in 58 paired hepatocellular carcinoma (HCC) tumors and adjacent nontumor tissues

Combined genome-wide allelotyping and co
Combined genome-wide allelotyping and copy number analysis identify frequent genetic losses without copy number reduction in medulloblastoma
✍ Jacqueline A. Langdon; Jayne M. Lamont; Debbie K. Scott; Sara Dyer; Emma Prebble 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 758 KB

## Abstract Detailed analysis of mechanisms of genetic loss for specific tumor suppressor genes (TSGs; e.g., __RB1, APC__ and __NF1__) indicates that TSG inactivation can occur by allelic loss of heterozygosity (LOH), without any alteration in DNA copy number. However, the role and prevalence of su

Integrative genome-wide analysis reveals
Integrative genome-wide analysis reveals a robust genomic glioblastoma signature associated with copy number driving changes in gene expression
✍ Marie de Tayrac; Amandine Etcheverry; Marc Aubry; Stephan Saïkali; Abderrahmane 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 941 KB

## Abstract Glioblastoma multiforme shows multiple chromosomal aberrations, the impact of which on gene expression remains unclear. To investigate this relationship and to identify putative initiating genomic events, we integrated a paired copy number and gene expression survey in glioblastoma usin

Overlapping high-resolution copy number
Overlapping high-resolution copy number alterations in cancer genomes identified putative cancer genes in hepatocellular carcinoma
✍ Chian-Feng Chen; En-Chi Hsu; Kuen-Tyng Lin; Pang-Hsien Tu; Hung-Wei Chang; Chin- 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 605 KB

Recurrent cancer genome aberrations are indicators of residing crucial cancer genes. Although recent advances in genomic technologies have led to a global view of cancer genome aberrations, the identification of target genes and biomarkers from the aberrant loci remains difficult. To facilitate sear

Integrated gene copy number and expressi
Integrated gene copy number and expression microarray analysis of gastric cancer highlights potential target genes
✍ Samuel Myllykangas; Siina Junnila; Arto Kokkola; Reija Autio; Ilari Scheinin; Tu 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 308 KB

## Abstract We performed an integrated array comparative genomic hybridization (aCGH) and expression microarray analysis of 8 normal gastric tissues and 38 primary tumors, including 25 intestinal and 13 diffuse gastric adenocarcinomas to identify genes whose expression is deregulated in association

DNA copy number alterations and expressi
DNA copy number alterations and expression of relevant genes in triple-negative breast cancer
✍ Wonshik Han; Eun-Mi Jung; Jihyoung Cho; Jong Won Lee; Ki-Tae Hwang; Song-Ju Yang 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 332 KB

## Abstract Triple‐negative breast cancer (TNBC) is defined by a lack of expression of estrogen, progesterone, and HER2 receptors, and genetically most of them fall into the basal subgroup of breast cancer. The important issue of TNBC is poorer clinical outcome and absence of effective targeted the